These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 2945768

  • 1. [Molecular mechanisms of thrombolytic therapy].
    Lijnen HR, Collen D.
    Haemostasis; 1986; 16 Suppl 4():3-15. PubMed ID: 2945768
    [No Abstract] [Full Text] [Related]

  • 2. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T.
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Sep; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 5. [Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent].
    Collen D.
    Verh K Acad Geneeskd Belg; 1982 Sep; 44(5-6):295-305. PubMed ID: 6223460
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Streptokinase or urokinase: the elements of choice].
    Pâques EP.
    Haemostasis; 1986 Sep; 16 Suppl 4():21-5. PubMed ID: 2429902
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).
    Fox KA, Bergmann SR, Sobel BE.
    Biochem Pharmacol; 1984 Jun 15; 33(12):1831-8. PubMed ID: 6233982
    [No Abstract] [Full Text] [Related]

  • 10. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
    Lijnen HR, Stump DC, Collen DC.
    Semin Thromb Hemost; 1987 Apr 15; 13(2):152-9. PubMed ID: 3114883
    [No Abstract] [Full Text] [Related]

  • 11. Fibrinolysis--a review.
    Kane KK.
    Ann Clin Lab Sci; 1984 Apr 15; 14(6):443-9. PubMed ID: 6239587
    [Abstract] [Full Text] [Related]

  • 12. Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin.
    Reed GL, Matsueda GR, Haber E.
    Proc Natl Acad Sci U S A; 1990 Feb 15; 87(3):1114-8. PubMed ID: 1689060
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The regulation of fibrinolysis].
    Matsuo O.
    Nihon Rinsho; 1989 Apr 15; 47(4):739-45. PubMed ID: 2526261
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization and antithrombotic action of tissue plasminogen activator.
    Bergqvist D, Nilsson IM, Pandolfi M.
    Experientia; 1984 Jan 15; 40(1):67-8. PubMed ID: 6229416
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.